In patients with ischemic stroke, serum GM-CSF levels are significantly higher than those in healthy individuals, and they correlate with the severity of neurological symptoms 12 h after stroke onset, moreover Ota et al. demonstrated that serum GM-CSF levels correlated positively with the severity of WMH in MPA patients [44]. The gene discussed is CSF2; the disease is Stroke.